Surgical Imaging Market Size

Surgical Imaging Market Analysis

The surgical imaging market is expected to register a CAGR of 6.1% over the forecast period.

During the initial phase of the COVID-19 pandemic, there was a severe reduction in the number of medical imaging services provided all over the world, owing to the fear of the risk of contamination, and the non-availability of certain imaging agents, such as radiotracers, which heavily impacted the growth of the market. For instance, as per the article published in November 2021 in PubMed, the COVID-19 epidemic resulted in a considerable decrease in radiology imaging and procedures. The overall reduction in radiology services was determined by the stage/period of lockdown, location, and imaging modality. As per the same source, a 76% reduction in ultrasound, 74 % reduction in MRI, and 66% reduction in mammography were reported. However, in the post-pandemic situation, as the restrictions are lifted, the market is gaining demand due to the advancements in surgical imaging techniques and the need for diagnostic imaging for chronic diseases.

Over the last decade, there has been a rise in the prevalence of several chronic diseases that need critical care diagnosis. The patients in the surgical intensive care unit frequently undergo laboratory and imaging testing. Several chronic diseases, such as hypertension, diabetes, obesity, and depression, amongst others, need critical care during their hospitalizations. The high prevalence of cardiovascular disorders is expected to boost the demand for surgical imaging services, thereby propelling the market growth. For instance, according to the 2022 UK Factsheet by BHF, over 7.6 million people in the United Kingdom were living with heart and circulatory diseases as of August 2022. The factsheet indicated that heart and circulatory diseases cost the nation over EUR 9 billion (USD 7.6 billion) every year. Moreover, the large population affected by cardiovascular diseases along with the associated high annual healthcare costs are expected to boost the growth of the studied market over the forecast period. Also, chronic obstructive pulmonary disease (COPD), a type of respiratory disease is chronic inflammation in the lungs that causes obstructed airflow from the lungs. The disease is generally diagnosed with the help of chest X-ray, CT, and magnetic resonance imaging (MRI). According to the research briefing by the United Kingdom House of Commons published in November 2021, there were over 1.17 million people in England who had been diagnosed with COPD, accounting for around 1.9% of the population. The huge population affected by COPD increases the demand for surgical imaging services for proper therapy and management, thereby propelling market growth over the forecast period.

Furthermore, product launches, the presence of competitors, mergers, and acquisitions relating to the surgical imaging field are likely to boost the market growth over the forecast period. For instance, in July 2022, Siemens Healthineers received approval from the FDA for the ARTIS icono ceiling, a ceiling-mounted C-arm angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. Furthermore, in April 2022, Wipro GE Healthcare, a medical technology, and digital solutions innovator launched its next-generation Revolution Aspire CT (Computed Tomography) scanner. Revolution Aspire is designed and manufactured end-to-end in India, at the newly launched Wipro GE Medical Devices Manufacturing plant, in line with the 'Atmanirbhar Bharat' initiative. Hence, such product launches associated with the surgical imaging field are likely to boost market growth over the forecast period.

Hence, due to the rise in chronic diseases and the increase in demand for minimally invasive procedures, the market for surgical imaging is anticipated to grow over the forecast period. However, the high procedural and equipment costs and the stringent regulatory guidelines are expected to restrict the market growth during the forecast period.